1. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Biomarkers Definitions Working Group;Clin. Pharmacol. Ther.,2011
2. The Evaluation of Surrogate Endpoints
3. International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use. (1998)ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. (http://www.ich.org/pdfICH/e9.pdf) Federal Register 63 No. 179 49583.
4. Prescription-event and other forms of epidemiological monitoring of side-effects in the UK
5. Validation of surrogate endpoints with examples from cancer clinical trials;Buyse M.;Biom. J.,2015